HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction to editorial
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wong, C-K
Right arrow Articles by White, H D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wong, C-K
Right arrow Articles by White, H D
Heart 2002;87:3-5
© 2002 by Heart


EDITORIAL

Recognising "painless" heart attacks

C-K Wong, H D White

Cardiovascular Research Unit, Green Lane Hospital, Private Bag 92 189, Auckland 1030, New Zealand

Correspondence to:
Correspondence to:
Professor White, Cardiovascular Research Unit, Green Lane Hospital, Private Bag 992 189, Auckland 1030, New Zealand;
harveyw@adhb.govt.nz


Heart attacks without chest pain all too often go unrecognised and untreated

Keywords: myocardial infarction; silent ischaemia; asymptomatic patients

Abbreviations: ACIP, asymptomatic cardiac ischemia pilot; EMMACE, evaluation of methods and management of acute coronary events

Ischaemic chest pain has been the hallmark of the clinical presentation of patients with acute coronary syndromes. New modalities for early diagnosis and treatment have been developed (for example, rapid troponin assays, glycoprotein IIb/IIIa receptor antagonists, anticoagulants, and facilitated percutaneous intervention), and cardiologists are now extending their reach to the emergency department—the portal of the hospital—in order to ensure that reperfusion and adjunctive treatments are instituted with minimal delay.1 Yet there has been relatively little evaluation of modern treatments in the context of "silent" myocardial infarction, a well recognised entity described by Herrick in 19122 and documented further in long term follow up of the Framingham Study.3

A recent issue of Heart featured the results of the EMMACE study, an audit of patient records from 20 adjacent hospitals in the Yorkshire region over a three month period in the mid 1990s.4 The authors identified 3684 consecutive cases with a possible . . . [Full text of this article]




This article has been cited by other articles:


Home page
HeartHome page
H L Koek, A de Bruin, A Gast, E Gevers, J W P F Kardaun, J B Reitsma, D E Grobbee, and M L Bots
Decline in incidence of hospitalisation for acute myocardial infarction in the Netherlands from 1995 to 2000
Heart, February 1, 2006; 92(2): 162 - 165.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C.-K. Wong and H.D. White
Has the mortality rate from acute myocardial infarction fallen substantially in recent years?
Eur. Heart J., May 1, 2002; 23(9): 689 - 692.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2002 BMJ Publishing Group Ltd & British Cardiovascular Society